Outcomes after liver and bile duct surgery at a high-volume center
Part of Cancer, Digestive system clinical trials.
This study looks at how patients fare after surgery for liver or bile duct conditions, including both benign and malignant diseases. It aims to understand and improve outcomes by reviewing the experiences of patients treated at a specialized center.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having (or have had) surgery to remove part of your liver or bile ducts.
- Your liver or bile duct condition is benign (non-cancerous) or malignant (cancerous).
- Your medical records, surgery details, and follow-up information are available for review.
- If you are joining the part of the study that looks ahead in time, you must be willing to sign a consent form, if required by local rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.
This study is collecting medical information and blood samples from people with bile duct or gallbladder tumors to build a database that can help doctors better understand these conditions and improve future treatments.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This registry collects information from people with liver cancer or bile duct cancer to learn more about the disease and its treatment. Anyone 18 or older with any stage of these cancers can join.
Hear when a new Liver Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.